ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03324932
Recruitment Status : Recruiting
First Posted : October 30, 2017
Last Update Posted : October 31, 2017
Sponsor:
Information provided by (Responsible Party):
Hisako Ono, MD, Kyoto Prefectural University of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2023